Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cara Therapeutics
(NQ:
CARA
)
0.3591
-0.0107 (-2.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cara Therapeutics
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Cannabis Stock Movers For March 14, 2022
March 14, 2022
GAINERS: Leviathan Natural Prods (OTC:
Via
Benzinga
Marijuana Stock Movers For March 9, 2022
March 09, 2022
GAINERS: MGC Pharmaceuticals (OTC:
Via
Benzinga
Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers
March 08, 2022
GAINERS: Nine Energy Service (NYSE:
Via
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
Cara Therapeutics To Host Virtual R&D On March 11
February 18, 2022
Cara Therapeutics, (NASDAQ:CARA) ...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
March 08, 2022
Raymond James cut the price target on Ciena Corporation (NYSE: CIEN) from $80 to $75. Ciena shares fell 10.9% to close at $58.76 on Monday. Telsey Advisory Group cut Capri...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...
Via
Benzinga
Looking Into Cara Therapeutics's Return On Capital Employed
March 03, 2022
Benzinga Pro data, Cara Therapeutics (NASDAQ:CARA) reported Q4 sales of $821.00 thousand. Earnings fell to a loss of $33.38 million, resulting in a 3195.36% decrease from last...
Via
Benzinga
Cara Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
March 01, 2022
Cara Therapeutics, Inc. (NASDAQ:CARA), an early commercial...
Via
Benzinga
Recap: Cara Therapeutics Q4 Earnings
March 01, 2022
Cara Therapeutics (NASDAQ:CARA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Cannabis Stock Gainers And Losers From February 2, 2022
February 02, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 7.14% at $1.20
Via
Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 10, 2022
On Thursday, 89 companies hit new 52-week lows. Noteable 52-Week Lows: The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:SGEN)....
Via
Benzinga
Cannabis Stock Gainers And Losers From January 27, 2022
January 27, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03
Via
Benzinga
Cannabis Stock Gainers And Losers From January 26, 2022
January 26, 2022
GAINERS: Item 9 Labs (OTC:
Via
Benzinga
Cannabis Stock Gainers And Losers From January 19, 2022
January 19, 2022
GAINERS: Heritage Cannabis Holding (OTC:
Via
Benzinga
Cannabis Stock Gainers And Losers From January 18, 2022
January 18, 2022
GAINERS: Item 9 Labs (OTC:
Via
Benzinga
Cannabis Stock Gainers And Losers From January 5, 2022
January 05, 2022
GAINERS: Rhinomed (OTC:
Via
Benzinga
Cannabis Stock Gainers And Losers From January 3, 2022
January 03, 2022
GAINERS: BioHarvest Sciences (OTC:
Via
Benzinga
Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack
December 14, 2021
Photo by Michael Longmire on...
Via
Benzinga
XPO Logistics (Formerly Segmentz) Founder and Grove Inc (GRVI) CEO Brings Deep Experience in Growing Companies
November 10, 2021
Image Provided By Pixabay The following post was...
Via
Benzinga
Cara Therapeutics, inc (CARA) Q3 2021 Earnings Call Transcript
November 08, 2021
CARA earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
November 03, 2021
These biotech stocks have recently been responsible for a slew of rocketship emojis.
Via
The Motley Fool
Is Cara Therapeutics Stock a Buy After Its First FDA Drug Approval
September 04, 2021
There's good news at long last for the beaten-down biotech stock.
Via
The Motley Fool
Exposures
Product Safety
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August 31, 2021
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New...
Via
Benzinga
64 Biggest Movers From Yesterday
October 28, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via
Benzinga
Why Cara Therapeutics Shot Higher Today
August 24, 2021
The biotech gets an important nod from a top regulator.
Via
The Motley Fool
Exposures
Product Safety
60 Biggest Movers From Yesterday
August 25, 2021
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...
Via
Benzinga
CARA Stock: The Huge FDA News Sending Cara Therapeutics Skyrocketing Today
August 24, 2021
Shares of CARA stock are ticking higher on Tuesday after the Cara Therapeutics' injection treatment was approved by the FDA.
Via
InvestorPlace
Exposures
Product Safety
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.